Choose an application
Cloning, Organism --- Cloning --- Stem Cell Transplantation --- Bioethical Issues --- Religion and Science --- Cloning, Organism --- Embryo Research --- Government Regulation --- Reproductive Techniques, Assisted --- ethics --- Ethics --- ethics --- legislation & jurisprudence --- ethics --- ethics
Choose an application
Choose an application
351.81 <492> --- Highway law --- -Railroad law --- -Government regulation of railroads --- Law, Railroad --- Railroads --- Concessions --- Corporation law --- Railroads and state --- Law, Highway --- Road law --- Roads --- Traffic safety --- Transportation --- Servitudes --- Verkeerswetgeving. Verkeersreglementering--Transportrecht zie {347.763}--Nederland --- Law and legislation --- Railroad law --- -Verkeerswetgeving. Verkeersreglementering--Transportrecht zie {347.763}--Nederland --- 351.81 <492> Verkeerswetgeving. Verkeersreglementering--Transportrecht zie {347.763}--Nederland --- Government regulation of railroads
Choose an application
Vingt ans après leur introduction en France, les médicaments génériques suscitent toujours la polémique. Pour les uns, ce sont d'authentiques médicaments, dont dépend la survie de notre système d'assurance maladie. Pour les autres, ce sont de piètres copies qui sacrifient la santé à l'économie. Le développement des génériques a reconfiguré le système de santé français, en bouleversant les relations d'alliance et de concurrence entre les pouvoirs publics, les industriels, les professionnels de santé et les patients. Il a également révélé les conflits de valeurs qui traversent notre société : égalité contre qualité, solidarité contre liberté.
Médicaments génériques --- Politique pharmaceutique --- Économie de la santé --- Politique publique --- Industrie et commerce --- Sociologie de la santé --- Generic drugs --- Drugs, Generic --- Drug Industry --- Government Regulation --- Legislation, Drug --- Drugs --- ethics --- Therapeutic equivalency --- Sociologie de la santé. --- Generic drugs - France --- Drugs, Generic - France --- Drug Industry - ethics - France --- Government Regulation - France --- Legislation, Drug - France --- Drugs - Therapeutic equivalency - France
Choose an application
Communicable Disease Control --- Communism --- Gesundheitspolitik. --- Gesundheitswesen. --- Government Regulation --- Health Policy --- Medical policy --- Medical policy. --- Public health --- Public health. --- trends --- China. --- S21/0500 --- China: Medicine, public health and food--Public health, hospitals, medical schools, etc
Choose an application
The work of a multidisciplinary research team, Transparent Lives explains why and how surveillance is expanding-mostly unchecked-into every facet of our lives.
Electronic surveillance --- Privacy, Right of --- Social control --- Social conflict --- Sociology --- Liberty --- Pressure groups --- Electronics in surveillance --- SIGINT (Electronic surveillance) --- Signals intelligence --- Surveillance, Electronic --- Remote sensing --- The New Transparency Project. --- big brother. --- government regulation. --- privacy. --- telecommunications.
Choose an application
"Biobanks are proliferating rapidly worldwide because they are powerful tools and organisational structures for undertaking medical research. By linking samples to data on the health of individuals, it is anticipated that biobanks will be used to explore the relationship between genes, environment and lifestyle for many diseases, as well as the potential of individually-tailored drug treatments based on genetic predisposition. However, they also raise considerable challenges for existing legal frameworks and research governance structures. This book critically examines the current governance structures in place for biobanks in England and Wales. It shows that the technologies, techniques and practices involved in biobanking do not always conform neatly to existing legal principles and frameworks that apply to other areas of medical research. Using a socio-legal approach, including interview data gathered from the scientific community, this book provides unique insights and makes recommendations about appropriate governance mechanisms for biobanking in the future. It also explores the issues around the secondary use of information, such as consent and how to protect privacy, when biobanks are accessed by a number of different third parties. These issues have relevance both within England and Wales and to a wide international audience, as well as for other areas where large datasets are used."--Bloomsbury Publishing.
Biobanks --- Bio-banks --- Biological specimen banks --- Biological resource centers --- Biological specimens --- Medical laws and legislation --- Law and legislation. --- Management. --- Law and legislation --- Management --- E-books --- Biological Specimen Banks --- Databases, Genetic --- Government Regulation --- Public Policy --- Law and legislation . --- Ethics --- Legislation & jurisprudence
Choose an application
United States monetary policy has traditionally been modeled under the assumption that the domestic economy is immune to international factors and exogenous shocks. Such an assumption is increasingly unrealistic in the age of integrated capital markets, tightened links between national economies, and reduced trading costs. International Dimensions of Monetary Policy brings together fresh research to address the repercussions of the continuing evolution toward globalization for the conduct of monetary policy. In this comprehensive book, the authors examine the
Monetary policy --- Globalization --- International finance --- globalization, monetary policy, trading costs, trade, international, finance, national economy, capital markets, integration, domestic shocks, currency, price, stability, nonfiction, economics, competition, inflation, liquidity, oil, macroeconomics, market imperfections, emerging economies, government, regulation, intervention.
Choose an application
Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual's purchasing power or lack of competent "agents" - health workers that are well trained to give the correct advice on which medicines to take. Pharmaceutical policy is the part of health policy that aims at addressing these problems and increasing access to safe, effective and affordable medicines for all patients. There ar
Pharmaceutical policy. --- Drug Industry --- Developed Countries. --- Government Regulation. --- Health Plan Implementation. --- Health Policy --- organization & administration. --- economics. --- Medical policy. --- Health care policy --- Health policy --- Medical care --- Medicine and state --- Policy, Medical --- Public health --- Public health policy --- State and medicine --- Science and state --- Social policy --- Drug policy --- Drugs --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Government policy --- Health Plan Implementation --- organization & administration --- economics --- Developed Countries --- Government Regulation
Choose an application
With contributions from a range of experts across OECD countries, this book examines changes in long-term care systems throughout those countries, discussing and comparing key changes in national policies and examining the main successes and failures of recent reforms.
Social policy --- Organisation for Economic Co-operation and Development --- Long-Term Care --- Health Care Reform --- Health Policy --- Government Regulation --- Developed Countries --- Soins à long terme --- Services de santé --- Politique sanitaire --- Réforme --- Organisation for Economic Co-operation and Development. --- Soins de longue durée --- Health Policy. --- Long-term care of the sick --- Government policy --- Long-Term Care. --- Health Care Reform. --- Government Regulation. --- Developed Countries. --- Care of the sick --- Medical care